10-Q 1 c97035e10vq.htm QUARTERLY REPORT e10vq
Table of Contents

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549-1004
FORM 10-Q
[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For The Quarterly Period Ended June 30, 2005
OR
[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from                     to                    
 
COMMISSION FILE NUMBER 1-11846
AptarGroup, Inc.
     
DELAWARE   36-3853103
(State of Incorporation)   (I.R.S. Employer Identification No.)
475 West Terra Cotta Avenue, Suite E, Crystal Lake, Illinois 60014
815-477-0424
Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes þ No ¨
Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act).
Yes þ No ¨
Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date (July 20, 2005).
Common Stock                    35,023,072

 


 
AptarGroup, Inc.
Form 10-Q
Quarter Ended June 30, 2005
INDEX
 
                 
Part I.          
       
 
       
Item 1.          
       
 
       
            1  
       
 
       
            2  
       
 
       
            4  
       
 
       
            5  
       
 
       
Item 2.       12  
       
 
       
Item 3.       20  
       
 
       
Item 4.       20  
       
 
       
Part II.          
       
 
       
Item 2.       21  
       
 
       
Item 4.       21  
       
 
       
Item 6.       22  
       
 
       
            23  
 Certification
 Certification
 Certification
 Certification
 
 i 

 


Table of Contents

PART I — FINANCIAL INFORMATION
ITEM 1. FINANCIAL STATEMENTS (UNAUDITED)
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
AptarGroup, Inc.
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(Unaudited)
In thousands, except per share amounts
 
                                 
    Three Months Ended June 30,     Six Months Ended June 30,  
    2005     2004     2005     2004  
 
                               
Net Sales
  $ 356,112     $ 311,844     $ 700,111     $ 627,447  
                     
Operating Expenses:
                               
Cost of sales
                               
(exclusive of depreciation shown below)
    238,641       206,202       471,119       417,783  
Selling, research & development and administrative
    51,060       46,793       102,700       95,062  
Depreciation and amortization
    25,282       23,433       50,814       47,483  
                     
 
    314,983       276,428       624,633       560,328  
                     
Operating Income
    41,129       35,416       75,478       67,119  
                     
Other Income (Expense):
                               
Interest expense
    (3,026 )     (2,495 )     (5,764 )     (4,724 )
Interest income
    747       872       1,562       1,890  
Equity in results of affiliates
    503       251       835       693  
Minority interests
    71       (153 )     71       (272 )
Miscellaneous, net
    (533 )     (388 )     (838 )     25  
                     
 
    (2,238 )     (1,913 )     (4,134 )     (2,388 )
                     
Income Before Income Taxes
    38,891       33,503       71,344       64,731  
 
                               
Provision for Income Taxes
    9,567       10,721       19,952       20,714  
                     
 
                               
Net Income
  $ 29,324     $ 22,782     $ 51,392     $ 44,017  
 
                       
 
                               
Net Income Per Common Share:
                               
Basic
  $ 0.83     $ 0.62     $ 1.45     $ 1.21  
 
                       
Diluted
  $ 0.81     $ 0.61     $ 1.41     $ 1.18  
 
                       
 
                               
Average Number of Shares Outstanding:
                               
Basic
    35,226       36,527       35,431       36,464  
Diluted
    36,321       37,462       36,526       37,377  
 
                               
Dividends Per Common Share
  $ .15     $ .07     $ .30     $ .14  
 
                       
See accompanying notes to condensed consolidated financial statements.

1


Table of Contents

CONDENSED CONSOLIDATED BALANCE SHEETS
AptarGroup, Inc.
CONDENSED CONSOLIDATED BALANCE SHEETS
(Unaudited)
In thousands, except per share amounts
 
                 
    June 30,     December 31,  
    2005     2004  
 
               
Assets
               
Current Assets:
               
Cash and equivalents
  $ 123,526     $ 170,368  
Accounts and notes receivable, less allowance for doubtful
accounts of $9,069 in 2005 and $9,952 in 2004
    277,971       266,894  
Inventories, net
    186,516       189,349  
Prepayments and other
    31,469       34,618  
         
 
    619,482       661,229  
         
 
               
Property, Plant and Equipment:
               
Buildings and improvements
    187,336       196,592  
Machinery and equipment
    1,021,387       1,073,173  
         
 
    1,208,723       1,269,765  
Less: Accumulated depreciation
    (721,445 )     (747,787 )
         
 
    487,278       521,978  
Land
    11,632       12,784  
         
 
    498,910       534,762  
         
 
               
Other Assets:
               
Investments in affiliates
    12,117       12,409  
Goodwill
    144,716       140,239  
Intangible assets, net
    12,854       14,472  
Miscellaneous
    19,272       10,915  
         
 
    188,959       178,035  
         
Total Assets
  $ 1,307,351     $ 1,374,026  
 
           
See accompanying notes to condensed consolidated financial statements.

2


Table of Contents

AptarGroup, Inc.
CONDENSED CONSOLIDATED BALANCE SHEETS
(Unaudited)
In thousands, except per share amounts
 
                 
    June 30,     December 31,  
    2005     2004  
 
               
Liabilities and Stockholders’ Equity
               
Current Liabilities:
               
Notes payable
  $ 77,688     $ 56,428  
Current maturities of long-term obligations
    6,260       6,864  
Accounts payable and accrued liabilities
    209,224       213,569  
         
 
    293,172       276,861  
         
Long-Term Obligations
    141,376       142,581  
         
 
               
Deferred Liabilities and Other:
               
Deferred income taxes
    39,616       45,169  
Retirement and deferred compensation plans
    26,782       26,673  
Deferred and other non-current liabilities
    2,037       2,313  
Minority interests
    6,577       7,232  
         
 
    75,012       81,387  
         
Commitments and Contingencies
           
         
 
               
Stockholders’ Equity:
               
Preferred stock, $.01 par value, 1 million shares authorized, none
outstanding
           
Common stock, $.01 par value, 38.4 and 38.2 million shares issued and outstanding at June 30, 2005 and December 31, 2004, respectively
    384       382  
Capital in excess of par value
    153,154       148,722  
Retained earnings
    736,641       695,901  
Accumulated other comprehensive income
    40,789       120,323  
Less treasury stock at cost, 3.4 and 2.6 million shares as of
June 30, 2005 and December 31, 2004, respectively.
    (133,177 )     (92,131 )
         
 
    797,791       873,197  
         
Total Liabilities and Stockholders’ Equity
  $ 1,307,351     $ 1,374,026  
 
           
See accompanying notes to condensed consolidated financial statements.

3


Table of Contents

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
AptarGroup, Inc.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
In thousands, brackets denote cash outflows
 
                 
Six Months Ended June 30,   2005     2004  
 
               
Cash Flows From Operating Activities:
               
Net income
  $ 51,392     $ 44,017  
Adjustments to reconcile net income to net cash provided by operations:
               
Depreciation
    49,593       46,344  
Amortization
    1,221       1,139  
Provision for bad debts
    207       324  
Minority interests
    (71 )     272  
Deferred income taxes
    (5,640 )     (15 )
Retirement and deferred compensation plans
    1,039       821  
Equity in results of affiliates in excess of cash distributions received
    (807 )     (693 )
Changes in balance sheet items, excluding
effects from foreign currency adjustments:
               
Accounts receivable
    (39,794 )     (18,532 )
Inventories
    (10,747 )     (15,256 )
Prepayments and other current assets
    (825 )     2,148  
Accounts payable and accrued liabilities
    17,162       12,514  
Income taxes payable
    2,622       6,870  
Other changes, net
    7,552       2,014  
         
Net Cash Provided by Operations
    72,904       81,967  
         
 
               
Cash Flows From Investing Activities:
               
Capital expenditures
    (49,433 )     (51,767 )
Proceeds from disposition of property and equipment
    1,633       4,481  
Acquisition of intangible assets
    (718 )     (1,241 )
Acquisition of business, net of cash acquired
    (29,345 )      
Issuance of notes receivable, net
    443       450  
         
Net Cash Used by Investing Activities
    (77,420 )     (48,077 )
         
Cash Flows From Financing Activities:
               
Proceeds/(repayments) from notes payable
    21,078       (26,411 )
Proceeds from long-term obligations
    589       25,000  
Repayments of long-term obligations
    (1,997 )     (3,146 )
Dividends paid to stockholders
    (10,652 )     (5,102 )
Proceeds from stock options exercises
    6,743       6,429  
Purchase of treasury stock
    (43,714 )     (3,892 )
         
Net Cash Used by Financing Activities
    (27,953 )     (7,122 )
         
 
               
Effect of Exchange Rate Changes on Cash
    (14,373 )     (4,682 )
         
Net (Decrease)/Increase in Cash and Equivalents
    (46,842 )     22,086  
Cash and Equivalents at Beginning of Period
    170,368       164,982  
         
Cash and Equivalents at End of Period
  $ 123,526     $ 187,068  
 
           
See accompanying notes to condensed consolidated financial statements.

4


Table of Contents

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
AptarGroup, Inc.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Amounts in Thousands, Except per Share Amounts, or Otherwise Indicated)
(Unaudited)
NOTE 1 — BASIS OF PRESENTATION
The accompanying unaudited consolidated financial statements include the accounts of AptarGroup, Inc. and its subsidiaries. The terms “AptarGroup” or “Company” as used herein refer to AptarGroup, Inc. and its subsidiaries.
     In the opinion of management, the unaudited consolidated financial statements include all adjustments, consisting of only normal recurring adjustments, necessary for the fair statement of consolidated financial position, results of operations, and cash flows for the interim periods presented. The accompanying unaudited consolidated financial statements have been prepared by the Company, without audit, pursuant to the rules and regulations of the Securities and Exchange Commission. Certain information and footnote disclosure normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (GAAP) have been condensed or omitted pursuant to such rules and regulations, although the Company believes that the disclosures made are adequate to make the information presented not misleading. Accordingly, these unaudited consolidated financial statements and related notes should be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2004. The results of operations of any interim period are not necessarily indicative of the results that may be expected for the year.
     At June 30, 2005 and June 30, 2004, the Company had stock-based employee compensation plans. The Company accounts for those plans under the recognition and measurement principles of APB Opinion No. 25, “Accounting for Stock Issued to Employees,” and related Interpretations. No stock-based employee compensation cost is reflected in net income relating to stock options, as all options granted under those plans had an exercise price equal to the market value of the underlying common stock on the date of grant. The following table illustrates the effect on net income and earnings per share if the Company had applied the fair value recognition provisions of SFAS No. 123, “Accounting for Stock-Based Compensation,” to stock-based employee compensation.
 
                                     
        Three Months Ended June 30,     Six Months Ended June 30,  
        2005     2004     2005     2004  
 
                                   
Net income, as reported   $ 29,324     $ 22,782     $ 51,392     $ 44,017  
Deduct:
  Total stock-based employee                                
 
  compensation expense determined                                
 
  under fair value based method for all                                
 
  awards, net of related tax effects     1,363       868       2,659       1,714  
                     
Pro forma net income   $ 27,961     $ 21,914     $ 48,733     $ 42,303  
 
                           
 
                                   
Earnings per share:                                
Basic — as reported
  $ 0.83     $ 0.62     $ 1.45     $ 1.21  
Basic — pro forma
  $ 0.79     $ 0.60     $ 1.38     $ 1.16  
Diluted — as reported
  $ 0.81     $ 0.61     $ 1.41     $ 1.18  
Diluted — pro forma
  $ 0.77     $ 0.58     $ 1.33     $ 1.13  
     SFAS No. 123R upon adoption requires the application of the non-substantive vesting approach which means that an award is fully vested when the employee’s retention of the award is no longer contingent on providing subsequent service. This would be the case for awards that vest when employees become retirement eligible or awards granted to retirement eligible employees. Had we been using the non-substantive approach instead of the nominal vesting approach when calculating the effect on net income and earnings per share above, net income would have decreased by approximately $0.6 million and $2.0 million for the quarter and six months ended June 30, 2005, respectively and $2.3 million and $2.0 million for the quarter and six months ended June 30, 2004 respectively.

5


Table of Contents

NOTE 2 — INVENTORIES
At June 30, 2005 and December 31, 2004, approximately 23% and 22%, respectively, of the total inventories are accounted for by using the LIFO method. Inventories, by component, consisted of:
 
                 
    June 30,     December 31,  
    2005     2004  
 
               
Raw materials
  $ 64,357     $ 62,785  
Work in progress
    44,733       47,130  
Finished goods
    80,855       82,263  
         
 
    189,945       192,178  
Less LIFO Reserve
    (3,429 )     (2,829 )
         
Total
  $ 186,516     $ 189,349  
 
           
NOTE 3 — GOODWILL AND OTHER INTANGIBLE ASSETS
The changes in the carrying amount of goodwill since the year ended December 31, 2004 are as follows by reporting segment:
 
                         
    Dispensing Systems     SeaquistPerfect        
    Segment     Segment     Total  
 
                       
Balance as of December 31, 2004
  $ 138,379     $ 1,860     $ 140,239  
Acquisitions (See Note 11)
          10,797       10,797  
Foreign currency exchange effects
    (5,417 )     (903 )     (6,320 )
               
Balance as of June 30, 2005
  $ 132,962     $ 11,754     $ 144,716  
 
                 
The table below shows a summary of intangible assets as of June 30, 2005 and December 31, 2004.
 
                                                         
            June 30, 2005     December 31, 2004  
    Weighted-                                          
    Average     Gross                     Gross              
    Amortization     Carrying     Accumulated     Net     Carrying     Accumulated     Net  
    Period     Amount     Amortization     Value     Amount     Amortization     Value  
 
                                                       
Amortized intangible assets:
                                                       
Patents
    15     $ 15,178     $ (7,030 )   $ 8,148     $ 17,852     $ (8,259 )   $ 9,593  
License agreements and other
    6       9,257       (5,496 )     3,761       9,093       (5,258 )     3,835  
 
                                           
 
    12       24,435       (12,526 )     11,909       26,945       (13,517 )     13,428  
 
                                           
Unamortized intangible assets:
                                                       
Trademarks
            452             452       505             505  
Pension asset
            493             493       539             539  
 
                                           
 
            945             945       1,044             1,044  
 
                                           
Total intangible assets
          $ 25,380     $ (12,526 )   $ 12,854     $ 27,989     $ (13,517 )   $ 14,472  
 
                                           
     Aggregate amortization expense for the intangible assets above for the quarters ended June 30, 2005 and 2004 was $612 and $553, respectively. Aggregate amortization expense for the intangible assets above for the six months ended June 30, 2005 and June 30, 2004 was $1,221 and $1,139, respectively.

6


Table of Contents

Estimated amortization expense for the years ending December 31 is as follows:
         
2005
  $ 2,294  
2006
    1,959  
2007
    1,933  
2008
    1,868  
2009
    1,610  
     Future amortization expense may fluctuate depending on changes in foreign currency rates. The estimates for amortization expense noted above are based upon foreign exchange rates as of June 30, 2005.
NOTE 4 — TOTAL COMPREHENSIVE (LOSS)/INCOME
AptarGroup’s total comprehensive income was as follows:
 
                                 
    Three Months Ended June 30,     Six Months Ended June 30,  
    2005     2004     2005     2004  
 
                               
Net income
  $ 29,324     $ 22,782     $ 51,392     $ 44,017  
Add: foreign currency translation adjustment
    (45,695 )     (6,054 )     (79,533 )     (21,251 )
                     
Total comprehensive income
  $ (16,371 )   $ 16,728     $ (28,141 )   $ 22,766  
 
                       
NOTE 5 — RETIREMENT AND DEFERRED COMPENSATION PLANS
Components of Net Periodic Benefit Cost:
 
Three months ended June 30,
                                 
    Domestic Plans     Foreign Plans  
    2005     2004     2005     2004  
 
                               
Service cost
  $ 899     $ 853     $ 251     $ 219  
Interest cost
    568       548       336       310  
Expected return on plan assets
    (547 )     (603 )     (113 )     (91 )
Amortization of prior service cost
    1       6       25       24  
Amortization of net loss
    114       73       70       56  
                     
Net periodic benefit cost
  $ 1,035     $ 877     $ 569     $ 518  
 
                       
Six months ended June 30,
                                 
    Domestic Plans     Foreign Plans  
    2005     2004     2005     2004  
 
                               
Service cost
  $ 1,892     $ 1,706     $ 511     $ 446  
Interest cost
    1,196       1,096       683       631  
Expected return on plan assets
    (1,151 )     (1,206 )     (230 )     (185 )
Amortization of prior service cost
    2       12       51       49  
Amortization of net loss
    240       146       143       114  
                     
Net periodic benefit cost
  $ 2,179     $ 1,754     $ 1,158     $ 1,055  
 
                       
EMPLOYER CONTRIBUTIONS
The Company previously disclosed in its financial statements for the year ended December 31, 2004, that it expected to contribute approximately $1.3 million to its domestic defined benefit plans and approximately $1.3 million to its foreign defined benefit plans in 2005. As of June 30, 2005, the Company has contributed approximately $.6 million to its foreign plans and has not yet contributed to its domestic plans. The Company presently anticipates contributing an additional $.7 million to fund its foreign plans and anticipates contributing approximately $1.3 million to its domestic plans before the end of 2005.

7


Table of Contents

NOTE 6 — DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES
The Company maintains a foreign exchange risk management policy designed to establish a framework to protect the value of the Company’s non-functional currency denominated transactions from adverse changes in exchange rates. Sales of the Company’s products can be denominated in a currency different from the currency in which the related costs to produce the product are denominated. Changes in exchange rates on such inter-country sales impact the Company’s results of operations. The Company’s policy is not to engage in speculative foreign currency hedging activities, but to minimize its net foreign currency transaction exposure defined as firm commitments and transactions recorded and denominated in currencies other than the functional currency. The Company may use foreign currency forward exchange contracts and collars, currency swaps, options and cross currency swaps to hedge these risks.
     The Company maintains an interest rate risk management strategy to minimize significant, unanticipated earnings fluctuations that may arise from volatility in interest rates.
     For derivative instruments designated as hedges, the Company formally documents the nature and relationships between the hedging instruments and the hedged items, as well as the risk management objectives, strategies for undertaking the various hedge transactions, and the method of assessing hedge effectiveness. Additionally, in order to designate any derivative instrument as a hedge of an anticipated transaction, the significant characteristics and expected terms of any anticipated transaction must be specifically identified, and it must be probable that the anticipated transaction will occur.
FAIR VALUE HEDGES
The Company has an interest rate swap to convert a portion of its fixed-rate debt into variable-rate debt. Under the interest rate swap contract, the Company exchanges, at specified intervals, the difference between fixed-rate and floating-rate amounts, which is calculated based on an agreed upon notional amount.
     As of June 30, 2005, the Company recorded the fair value of derivative instrument assets of $2.4 million in miscellaneous other assets with an offsetting adjustment to debt related to the fixed-to-variable interest rate swap agreement with a notional principal value of $25 million. No gain or loss was recorded in the income statement for the three or six months ended June 30, 2005 or June 30, 2004 since there was no hedge ineffectiveness.
CASH FLOW HEDGES
The Company did not use any cash flow hedges in the quarters or six months ended June 30, 2005 or June 30, 2004.
HEDGE OF NET INVESTMENTS IN FOREIGN OPERATIONS
A significant number of the Company’s operations are located outside of the United States. Because of this, movements in exchange rates may have a significant impact on the translation of the financial condition and results of operations of the Company’s foreign entities. A weakening U.S. dollar relative to foreign currencies has an additive translation effect on the Company’s financial condition. Conversely, a strengthening U.S. dollar has a dilutive effect. The Company in some cases maintains debt in these subsidiaries to offset the net asset exposure. The Company does not otherwise actively manage this risk using derivative financial instruments. In the event the Company plans on a full or partial liquidation of any of its foreign subsidiaries where the Company’s net investment is likely to be monetized, the Company will consider hedging the currency exposure associated with such a transaction.
OTHER
As of June 30, 2005, the Company recorded the fair value of foreign currency forward exchange contracts of $1.3 million in accounts payable and accrued liabilities in the balance sheet. All forward exchange contracts outstanding as of June 30, 2005 had an aggregate contract amount of $79.2 million.
NOTE 7 — COMMITMENTS AND CONTINGENCIES
The Company started construction of a new 90,000 square foot manufacturing facility in Italy to be used to manufacture spray through overcaps and aerosol valve accessories. The factory is estimated to cost approximately $9 million and will be financed through internally generated cash.
     The Company, in the normal course of business, is subject to a number of lawsuits and claims both actual and potential in nature. Management believes the resolution of these claims and lawsuits will not have a material adverse or positive effect on the Company’s financial position, results of operations or cash flow.
     Under its Certificate of Incorporation, the Company has agreed to indemnify its officers and directors for certain events or occurrences while the officer or director is, or was serving, at its request in such capacity. The maximum potential amount of future payments the Company could be required to make under these indemnification agreements is unlimited; however, the Company has a directors and officers liability insurance policy that covers a portion of its exposure. As a result of its insurance policy coverage, the Company believes the estimated fair value of these indemnification agreements is minimal. The Company has no liabilities recorded for these agreements as of June 30, 2005.

8


Table of Contents

NOTE 8 — STOCK REPURCHASE PROGRAM
During the quarter ended June 30, 2005, the Company repurchased 631 thousand shares for an aggregate amount of $31.4 million. As of June 30, 2005, the Company has outstanding authorizations to repurchase up to approximately 1.5 million shares. The timing of and total amount expended for the share repurchase depends upon market conditions.
NOTE 9 — EARNINGS PER SHARE
AptarGroup’s authorized common stock consists of 99 million shares, having a par value of $0.01 each. Information related to the calculation of earnings per share is as follows:
 
                                 
    Three months ended  
    June 30, 2005     June 30, 2004  
    Diluted     Basic     Diluted     Basic  
 
                               
Consolidated operations
                               
Income available to common stockholders
  $ 29,324     $ 29,324     $ 22,782     $ 22,782  
                     
 
                               
Average equivalent shares
                               
Shares of common stock
    35,226       35,226       36,527       36,527  
Dilutive effect of:
                               
Stock options
    1,089             925        
Restricted stock
    6             10        
                     
Total average equivalent shares
    36,321       35,226       37,462       36,527  
                     
Net income per share
  $ 0.81     $ 0.83     $ 0.61     $ 0.62  
 
                       
                                 
    Six months ended  
    June 30, 2005     June 30, 2004  
    Diluted     Basic     Diluted     Basic  
 
                               
Consolidated operations
                               
Income available to common stockholders
  $ 51,392     $ 51,392     $ 44,017     $ 44,017  
                     
 
                               
Average equivalent shares
                               
Shares of common stock
    35,431       35,431       36,464       36,464  
Dilutive effect of:
                               
Stock options
    1,087             905       --  
Restricted stock
    7             8        
                     
Total average equivalent shares
    36,526       35,431       37,377       36,464  
                     
Net income per share
  $ 1.41     $ 1.45     $ 1.18     $ 1.21  
 
                       
NOTE 10 — SEGMENT INFORMATION
The Company operates in the packaging components industry, which includes the development, manufacture and sale of consumer product dispensing systems. The Company is organized primarily based upon individual business units, which resulted from historic acquisitions or internally created business units. All of the business units sell primarily dispensing systems. These business units all require similar production processes, sell to similar classes of customers and markets, use the same methods to distribute products and operate in similar regulatory environments. Based on the current economic characteristics of the Company’s business units, the Company has identified two reportable segments: Dispensing Systems and SeaquistPerfect.
     The Dispensing Systems segment is an aggregate of four of the Company’s five business units. The Dispensing Systems segment sells primarily non-aerosol spray and lotion pumps, plastic dispensing and non-dispensing closures, and metered dose aerosol valves. These three products are sold to all of the markets served by the Company including the fragrance/cosmetic, pharmaceutical, personal care, household, and food/beverage markets.

9


Table of Contents

     SeaquistPerfect represents the Company’s fifth business unit and sells primarily aerosol valves and accessories and certain non-aerosol spray and lotion pumps. These products are sold primarily to the personal care, household, and food/beverage markets.
     The accounting policies of the segments are the same as those described in Note 1, Summary of Significant Accounting Policies in the Company’s Annual Report on Form 10-K for the year ended December 31, 2004. The Company evaluates performance of its business units and allocates resources based upon earnings before interest expense in excess of interest income, corporate expenses, income taxes and unusual items (collectively referred to as “Segment Income”). The Company accounts for intersegment sales and transfers as if the sales or transfers were to third parties.
Financial information regarding the Company’s reportable segments is shown below:
 
                                 
                    Corporate        
Quarter ended June 30,   Dispensing Systems     SeaquistPerfect     and Other     Totals  
 
                               
Total Revenue
                               
2005
  $ 294,485     $ 64,152     $     $ 358,637  
2004
    261,879       52,054             313,933  
 
                               
Less: Intersegment Sales
                               
2005
  $ 743     $ 1,782     $     $ 2,525  
2004
    887       1,202             2,089  
 
                               
Net Sales
                               
2005
  $ 293,742     $ 62,370     $     $ 356,112  
2004
    260,992       50,852             311,844  
 
                               
Segment Income
                               
2005
  $ 39,700     $ 6,329     $ (4,859 )   $ 41,170  
2004
    34,970       4,758       (4,602 )     35,126  
 
                    Corporate        
Six Months ended June 30,   Dispensing Systems     SeaquistPerfect     and Other     Totals  
 
                               
Total Revenue
                               
2005
  $ 575,801     $ 129,610     $     $ 705,411  
2004
    524,114       107,815             631,929  
 
                               
Less: Intersegment Sales
                               
2005
  $ 1,401     $ 3,899     $     $ 5,300  
2004
    1,672       2,810             4,482  
 
                               
Net Sales
                               
2005
  $ 574,400     $ 125,711     $     $ 700,111  
2004
    522,442       105,005             627,447  
 
                               
Segment Income
                               
2005
  $ 71,827     $ 13,073     $ (9,354 )   $ 75,546  
2004
    66,267       10,050       (8,752 )     67,565  

10


Table of Contents

Reconciliation of Segment Income to consolidated income before income taxes is as follows:
 
                                 
    Three Months Ended June 30,     Six Months Ended June 30,  
    2005     2004     2005     2004  
 
                               
Income before income taxes
                               
Total EBIT for reportable segments
  $ 41,170     $ 35,126     $ 75,546     $ 67,565  
Interest expense, net
    (2,279 )     (1,623 )     (4,202 )     (2,834 )
                     
Income before income taxes
  $ 38,891     $ 33,503     $ 71,344     $ 64,731  
NOTE 11 — ACQUISITIONS
During the first quarter of 2005, the Company acquired 100% of voting equity interest of EP Spray System SA for approximately $30 million in cash. No debt was assumed in the transaction. EP Spray System SA is a Swiss company that manufactures aerosol valves with bag-on-valve technology. This technology expands the Company’s aerosol valve product offerings. The Company is in the process of completing a fair market valuation of the assets and liabilities of EP Spray Systems SA and as of the date of this report, that information was not yet available. As a result, the full amount of the excess of the purchase price over the net book value of EP Spray Systems SA (approximately $10.8 million) was assigned to goodwill as of June 30, 2005 (as the net book value represents the Company’s best estimate of the fair value of the net assets at this time). The Company expects that the valuation of assets and liabilities and the associated purchase price allocation will be completed as soon as practicable. The condensed consolidated income statement includes the results of operations of EP Spray from February 28, 2005, the date of the acquisition.
NOTE 12 — SUBSEQUENT EVENT
On July 20, 2005, the Board of Directors increased the quarterly dividend to $0.20 per share from the previous level of $0.15 per share. This increase in dividends is expected to increase the cash payments of dividends for the second half of the year by approximately $3.5 million.

11


Table of Contents

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
AND RESULTS OF OPERATIONS
(AMOUNTS IN THOUSANDS, EXCEPT PER SHARE AMOUNTS, OR OTHERWISE INDICATED)
RESULTS OF OPERATIONS
 
                                 
    Three Months Ended June 30,     Six Months Ended June 30,  
    2005     2004     2005     2004  
 
                               
Net Sales
    100.0 %     100.0 %     100.0 %     100.0 %
Cost of sales (exclusive of depreciation shown below)
67.0       66.1       67.3       66.6  
Selling, research & development and administration
14.4       15.0       14.7       15.1  
Depreciation and amortization
    7.1       7.5       7.2       7.6  
                     
Operating Income
    11.5       11.4       10.8       10.7  
Other income (expense)
    (0.6 )     (0.7 )     (0.6 )     (0.4 )
                     
Income before income taxes
    10.9       10.7       10.2       10.3  
                     
 
                               
Net income
    8.2 %     7.3 %     7.3 %     7.0 %
 
               
 
                               
Effective Tax Rate
    24.6 %     32.0 %     28.0 %     32.0 %
NET SALES
Net sales for the quarter and six months ended June 30, 2005 were $356.1 million and $700.1 million, respectively, and represented increases of 14% and 12%, respectively, over the same periods a year ago. Changes in currency rates from 2004 to 2005 accounted for approximately 3% and 4% of the increase in sales, while sales of EP Spray System SA contributed approximately 1% of the sales growth for the quarter and six month periods, respectively. Excluding changes in foreign currency rates, the changes in sales by market were as follows:
    Our sales to the personal care market increased approximately 19% and 16% for the quarter and six months ended June 30, 2005, respectively, reflecting a broad based increase in demand of our dispensing closures product range, continued acceptance of our aerosol valve new product introductions such as our turning/locking actuator and sales of bag-on valves from the acquisition of EP Spray System SA. Resin related price increases are also having a positive impact in this market, primarily related to sales of our dispensing closures.
    Our sales to the fragrance/cosmetic market remained relatively constant for the quarter and increased approximately 2% for the six months ended June 30, 2005 compared to the same period a year ago. Continued price pressure in this market and a general weakness in demand in this market are the primary contributing factors to the lack of growth.
    Our sales to the pharmaceutical market increased approximately 15% and 3% for the quarter and six months ended June 30, 2005, respectively. Tooling sales to this market contributed approximately 9% of the increase in sales in the quarter. For the six months ended, tooling sales were flat compared to the same period a year ago. The increase in sales to this market excluding tooling sales was derived primarily from an increase in demand of our spray pumps. Sales of our metered valves for the quarter and six months ended June 30, 2005 were slower than expected, but sales of this product line to the pharmaceutical market are expected to improve over the remainder of the year.
    Our sales to the food/beverage markets increased approximately 12% and 16% for the quarter and six months ended June 30, 2005, reflecting the continued acceptance of our dispensing closure product range in this market and offsetting a reduction in sales of tooling to customers in both the quarter and six months ended June 30, 2005. Excluding sales of tooling to customers, sales increased approximately 22% and 23% for the quarter and six month ending June 30, 2005, respectively.
    Our sales to the household market increased approximately 7% and 9% for the quarter and six months ended June 30, 2005, respectively, reflecting an increase in demand for aerosol valves.

12


Table of Contents

The following table sets forth, for the periods indicated, net sales by geographic location:
 
                                                                 
    Three Months Ended June 30,     Six Months Ended June 30,  
    2005     % of Total     2004     % of Total     2005     % of Total     2004     % of Total  
 
                                                               
Domestic
  $ 111,169       31 %   $ 94,433       30 %   $ 213,335       30 %   $ 184,882       29 %
Europe
    213,389       60 %     188,391       61 %     423,582       61 %     388,110       62 %
Other Foreign
    31,554       9 %     29,020       9 %     63,194       9 %     54,455       9 %
COST OF SALES (EXCLUSIVE OF DEPRECIATION SHOWN BELOW)
Our cost of sales as a percent of net sales increased to 67.0% in the second quarter compared to 66.1% in the second quarter of 2004. The following factors influenced the increase in our cost of sales percentage for the quarter ended June 30, 2005:
Rising Raw Material Costs.       Raw material costs, in particular plastic resin costs, remained significantly higher in the second quarter of 2005 compared to the second quarter of 2004. While most of this raw material cost increase has been passed on to customers in the form of selling price increases, the net effect is a reduction in margin percentage.
Strengthening of the Euro.       We are a net exporter from Europe of products produced in Europe with costs denominated in Euros. As a result, when the Euro strengthens against the U.S. dollar or other currencies, products produced in and exported from Europe and sold in currencies which have weakened against the Euro increase our costs, thus having a negative impact on cost of sales as a percentage of net sales.
Customer Milestone Payment.       In the second quarter of 2004, we recorded a $1 million milestone payment for creating a new pharmaceutical spray pump actuator. This milestone payment positively impacted the cost of sales as a percentage of net sales in 2004 and did not repeat in 2005.
Partially offsetting these negative factors was the following positive factor:
Operating Losses and Shut Down Expenses for a Mold Manufacturing Facility in the U.S.       We decided in the first quarter of 2004 to close a mold manufacturing facility in the U.S. Due to a reduction in the volume of business in the second quarter of 2004, this facility lost approximately $600 thousand. In addition, approximately $400 thousand of shut down and related severance charges were recorded relating to approximately 40 people and were included in cost of goods sold during the second quarter 2004. These expenses did not repeat in 2005.
Our cost of sales as a percent of net sales increased to 67.3% for the six months ended June 30, 2005 compared to 66.6% for the same period a year ago. In addition to the items already mentioned above relating to the second quarter, the following factors influenced the increase in our cost of sales percentage in the first half of 2005:
Sale of Building.       In the first quarter of 2004, we sold a production facility and realized a gain on the sale of the building of approximately $1 million. This gain positively impacted cost of goods sold in the first half of 2004 and did not repeat in 2005.
Partially offsetting this negative factor was the following positive factor:
Operating Losses and Shut Down Expenses for a Mold Manufacturing Facility in the U.S.       Due to the reduction in the volume of business in the first half of 2004, this facility lost approximately $1.3 million. In addition, approximately $900 thousand of shut down and related severance charges were recorded relating to approximately 40 people and were included in cost of goods sold during the first half of 2004. These expenses did not repeat in 2005.

13


Table of Contents

SELLING, RESEARCH & DEVELOPMENT AND ADMINISTRATIVE
Our Selling, Research & Development and Administrative expenses (“SG&A”) increased by approximately $4.3 million in the second quarter of 2005 compared to the same period a year ago. Approximately $1.5 million of the increase in SG&A is related to the strengthened Euro versus the U.S. dollar compared to the prior year. The remainder of the increase is due to normal inflationary costs and wage increases. SG&A as a percentage of net sales for the quarter ended June 30, 2005 decreased to 14.4% from 15.0% in 2004.
     Our SG&A costs increased approximately $7.6 million for the six months ended June 30, 2005 compared to the same period a year ago. Changes in foreign currency rates accounted for approximately $3.2 million of the increase in SG&A costs. The remainder of the increase is due to normal inflationary costs and wage increases. SG&A as a percentage of net sales for the six months ended June 30, 2005 decreased to 14.7% from 15.1% in 2004.
DEPRECIATION AND AMORTIZATION
Depreciation and amortization increased approximately $1.9 million in the second quarter of 2005 to $25.3 million compared to $23.4 million in the second quarter of 2004. Approximately $0.8 million of the increase is due to changes in foreign currency rates compared to the U.S. dollar in 2005. The remaining increase primarily relates to increased capital expenditures in prior years to support the growth of our business.
     Depreciation and amortization increased approximately $3.3 million for the first six months of 2005 to $50.8 million compared to $47.5 million for the first six months of 2004. Approximately $1.6 million of the increase is due to changes in foreign currency rates compared to the U.S. dollar in 2004. The remaining increase primarily relates to increased capital expenditures in prior years.
NET OTHER EXPENSE
Net other expenses in the second quarter of 2005 increased to $2.2 million from $1.9 million in the prior year primarily reflecting increased interest expense of $0.5 million due to an increase in short term borrowing rates. Included in net other expense is approximately $0.4 million of foreign currency losses reflecting the liquidation of a small finance operation in Europe.
     Net other expenses for the six months ended June 30, 2005 increased to $4.1 million from $2.4 million in the prior year primarily due to increased interest expense of $1.0 million related to an increase in short term borrowing rates, a decrease in interest income of approximately $0.3 million reflecting the decrease in cash levels from the prior year and an increase in foreign currency exchange losses of approximately $1 million which includes the $0.4 million described above.
EFFECTIVE TAX RATE
The reported effective tax rate for the three months ended June 30, 2005 was 24.6% compared to 32.0% for the same period a year ago. The decrease in the effective tax rate is attributed to prior years’ research and development credits of approximately $1.2 million realized in the second quarter of 2005. In addition, due to a special one-time Italian tax law policy relating to taxation of previously issued government grants, we were able to reduce certain previously recorded deferred tax liabilities by approximately $2 million.
     The reported effective tax rate for the six months ended June 30, 2005 was 28.0% compared to 32.0% for the same period a year ago. The same two positive impacts mentioned above are the primary reasons for the decrease in the effective tax rate for the first half of the year. We anticipate the effective tax rate to be in the range of 32.0% and 32.5% for the remainder of 2005.
NET INCOME
We reported net income for the second quarter of 2005 of $29.3 million compared to $22.8 million reported in the second quarter of 2004. Net income for the six months ended June 30, 2005 was $51.4 million compared to $44.0 million for the first six months of the prior year.
DISPENSING SYSTEMS SEGMENT
The Dispensing Systems segment is an aggregate of four of our five business units. The Dispensing Systems segment sells primarily non-aerosol spray and lotion pumps, plastic dispensing closures, and metered dose aerosol valves. These three products are sold to all the markets we serve.

14


Table of Contents

 
                                 
    Three Months Ended June 30,     Six Months Ended June 30,  
    2005     2004     2005     2004  
 
                               
Net Sales
  $ 293,742     $ 260,992     $ 574,400     $ 522,442  
Segment Income (1)
    39,700       34,970       71,827       66,267  
Segment Income as a percentage of Net Sales
    14 %     13 %     13 %     13 %
(1)   Segment Income is defined as earnings before net interest, corporate expenses, income taxes and unusual items. The Company evaluates performance of its business units and allocates resources based upon Segment Income. For a reconciliation of Segment Income to income before income taxes, see Note 10 — Segment information to the Consolidated Financial Statements in Item 1.
     Our net sales for the Dispensing Systems segment grew by approximately 13% in the second quarter of 2005 over the second quarter of 2004 reflecting strong sales of our dispensing closure product range to the personal care and food/beverage markets as well as increased sales of our pumps to the pharmaceutical market. The strengthening Euro also helped contribute to the sales increase. Net sales excluding changes in foreign currency exchange rates increased approximately 9% from the prior year.
     Net sales for the Dispensing Systems segment grew approximately 10% in the first six months of 2005 compared to the first six months of 2004 for the same reasons noted above in the second quarter. Net sales for the first half of the year excluding changes in foreign currency exchange rates increased approximately 6% from the prior year.
     Segment Income in the second quarter of 2005 increased approximately 14% to $39.7 million compared to $35.0 million reported in the prior year. The increase in Segment Income from the prior year is primarily related to the increase in dispensing closure sales volume as well as operating losses and shut down costs of approximately $1 million attributed to a mold making operation in 2004 that did not repeat in 2005.
     Segment Income in the first six months of 2005 increased approximately 8% to $71.8 million compared to $66.3 million reported in the first six months of the prior year. The increase in Segment Income from the prior year is mainly due to the same reasons noted above for the second quarter. Year to date operating losses and shut down costs for the first six months of 2004 that did not repeat in 2005 amounted to approximately $2.2 million.
SEAQUISTPERFECT SEGMENT
SeaquistPerfect represents our fifth business unit and sells primarily aerosol valves and accessories and certain non-aerosol spray and lotion pumps. These products are sold primarily to the personal care, household, and food/beverage markets.
 
                                 
    Three Months Ended June 30,     Six Months Ended June 30,  
    2005     2004     2005     2004  
 
                               
Net Sales
  $ 62,370     $ 50,852     $ 125,711     $ 105,005  
Segment Income
    6,329       4,758       13,073       10,050  
Segment Income as a percentage of Net Sales
    10 %     9 %     10 %     10 %
     Net sales for the quarter ended June 30, 2005 increased approximately 23% to $62.4 million from $50.9 million reported in the second quarter of the prior year. Net sales excluding changes in foreign currency exchange rates increased approximately 20% from the prior year. Approximately $4.1 million of the increase in sales is attributed to the acquisition of EP Spray Systems SA in the first quarter of 2005. The remainder of the increase in sales reflects strong sales of new aerosol product accessories such as the turning/locking actuator to the personal care market.
     Net sales for the SeaquistPerfect segment for the first six months of 2005 increased approximately 20%, or $20.7 million, compared to the first six months of the prior year. Net sales excluding changes in foreign currency exchange rates increased approximately 17% from the prior year. Sales from EP Spray Systems SA accounted for approximately $6.1 million of the sales increase. The remaining sales increase is mainly due to the same reasons noted above for the second quarter.

15


Table of Contents

     Segment Income in the second quarter of 2005 increased approximately 33% to $6.3 million compared to $4.8 million reported in the prior year. EP Spray Systems contributed approximately $1.1 million of the increase in Segment Income in the quarter. The remaining increase in Segment Income is due primarily to the increase in sales volumes mentioned above combined with continued cost savings and better overhead utilization.
     Segment Income in the first six months of 2005 increased approximately 30% to $13.1 million compared to $10.1 million reported in the first six months of the prior year reflecting the increased sales volumes combined with productivity improvements. EP Spray Systems contributed approximately $1.7 million of the increase in Segment Income.
FOREIGN CURRENCY
A significant number of our operations are located outside of the United States. Because of this, movements in exchange rates may have a significant impact on the translation of the financial statements of our foreign entities. Our primary foreign exchange exposure is to the Euro, but we have foreign exchange exposure to South American and Asian currencies, among others. We manage our foreign exchange exposures principally with forward exchange contracts to hedge certain transactions and firm purchase and sales commitments denominated in foreign currencies. A weakening U.S. dollar relative to foreign currencies has an additive translation effect on our financial statements. Conversely, a strengthening U.S. dollar has a dilutive effect. In some cases, we sell products denominated in a currency different from the currency in which the related costs are incurred. Changes in exchange rates on such inter-country sales could materially impact our results of operations.
QUARTERLY TRENDS
Our results of operations in the second half of the year typically are negatively impacted by customer plant shutdowns in the summer months in Europe and plant shutdowns in December. In the future, our results of operations in a quarterly period could be impacted by factors such as changes in product mix, changes in material costs, changes in growth rates in the industries to which our products are sold, and changes in general economic conditions in any of the countries in which we do business.
LIQUIDITY AND CAPITAL RESOURCES
Our primary sources of liquidity are cash flow from operations and our revolving credit facility. Cash and equivalents decreased to $123.5 million from $170.4 million at December 31, 2004. Total short and long-term interest bearing debt increased in the first half of 2005 to $225.3 million from $205.9 million at December 31, 2004. The ratio of Net Debt (interest bearing debt less cash and cash equivalents) to Net Capital (stockholder’s equity plus Net Debt) increased to approximately 11% compared to 4% as of December 31, 2004.
     In the first half of 2005, our operations provided approximately $72.9 million in cash flow compared to $82.0 million for the same period a year ago. In both periods, cash flow from operations was primarily derived from earnings before depreciation and amortization. The increase in profitability before depreciation expense was more than offset by increases in working capital needs to support the growth of our business. During the first half of 2005, we utilized the operating cash flows to finance capital expenditures, pay dividends and repurchase the Company’s common stock.
     We used $77.4 million in cash for investing activities during the first half of 2005, compared to $48.1 million during the same period a year ago. The increase in cash used for investing activities is due primarily to the acquisition of EP Spray Systems SA in the first quarter of 2005. The acquisition of the company in Switzerland was paid for using existing cash in Europe. Cash outlays for capital expenditures for 2005 are estimated to be approximately $100 million.
     Cash used by financing activities was $28.0 million in the first half of 2005 compared to $7.1 million in the same period a year ago. An increase in short-term debt of $21 million and approximately $30 million in cash repatriated from Europe (related to 2004 earnings) was used for share repurchases of the Company’s common stock and an increase in dividends paid to shareholders. Last year’s $7.1 million cash used by financing activities included $25 million in proceeds from a private placement.
     The Board of Directors declared a quarterly dividend of $.20 per share payable on August 23, 2005, an increase over the previous level of $.15 per share. This increase in dividends is expected to increase the cash used by financing activities for the second half of the year by approximately $3.5 million.

16


Table of Contents

     Our revolving credit facility and certain long-term obligations require us to satisfy certain financial and other covenants including:
             
    Requirement   Level at June 30, 2005
Interest coverage ratio
  At least 3.5 to 1   23 to 1
Debt to total capital ratio
  No more than 55%   22%  
     Based upon the above interest coverage ratio covenant, we could borrow additional debt up to a limit where interest expense would not exceed approximately $61 million. Actual interest expense for the past four quarters was approximately $11 million. Based upon the above debt to capital ratio covenant we would have the ability to borrow an additional $750 million before the 55% requirement would be exceeded.
     Our foreign operations have historically met cash requirements with the use of internally generated cash or borrowings. Foreign subsidiaries have financing arrangements with several foreign banks to fund operations located outside the U.S., but all these lines are uncommitted. Cash generated by foreign operations has generally been reinvested locally. The majority of our $123.5 million in cash and equivalents is located outside of the U.S.
     We believe we are in a strong financial position and have the financial resources to meet business requirements in the foreseeable future. We have historically used cash flow from operations as our primary source of liquidity. In the event that customer demand would decrease significantly for a prolonged period of time and negatively impact cash flow from operations, we would have the ability to restrict and significantly reduce capital expenditure levels, which historically have been the most significant use of cash for us. A prolonged and significant reduction in capital expenditure levels could increase future repairs and maintenance costs as well as have a negative impact on operating margins if we were unable to invest in new innovative products.
OFF-BALANCE SHEET ARRANGEMENTS
We lease certain warehouse, plant and office facilities as well as certain equipment under noncancelable operating leases expiring at various dates through the year 2018. Most of the operating leases contain renewal options and certain equipment leases include options to purchase during or at the end of the lease term. We have an option on one building lease to purchase the building during or at the end of the term of the lease at approximately the amount expended by the lessor for the purchase of the building and improvements, which was the fair value of the facility at the inception of the lease. This lease has been accounted for as an operating lease. If the Company exercises its option to purchase the building, the Company would account for this transaction as a capital expenditure. If the Company does not exercise the purchase option by the end of the lease in 2008, the Company would be required to pay an amount not to exceed $9.5 million and would receive certain rights to the proceeds from the sale of the related property. The value of the rights to be obtained relating to this property is expected to exceed the amount paid if the purchase option is not exercised. Other than operating lease obligations, we do not have any off-balance sheet arrangements.
ADOPTION OF ACCOUNTING STANDARDS
In May 2005 the Financial Accounting Standards Board, (“FASB”) issued Statement of Financial Accounting Standards (“SFAS”) No. 154 “Accounting Changes and Error Corrections.” SFAS No. 154 replaces Accounting Principles Board (“APB”) Opinion No. 20 and SFAS No. 3. SFAS No. 154 provides guidance on the accounting for and reporting of accounting changes and error corrections. SFAS No. 154 is effective for accounting changes and corrections of errors made in fiscal years beginning after December 15, 2005. We will adopt this Statement beginning January 1, 2006.
     In November 2004, the FASB issued SFAS No. 151 “Inventory Costs.” SFAS No. 151 amends the guidance in Accounting Research Bulletin (“ARB”) No. 43, Chapter 4, “Inventory Pricing,” to clarify the abnormal amounts of idle facility expense, freight, handling costs, and wasted material (spoilage). Paragraph 5 of ARB No. 43, Chapter 4 previously stated that “...under some circumstances, items such as idle facility expense, excessive spoilage, double freight, and rehandling costs may be so abnormal as to require treatment as current period charges...” SFAS No. 151 requires that those items be recognized as current period charges regardless of whether they meet the criterion of “so abnormal.” In addition, SFAS No. 151 requires that allocation of fixed production overheads to the costs of conversion be based on the normal capacity of the production facilities. SFAS No. 151 is effective for inventory costs incurred during fiscal years beginning after June 15, 2005. We have performed a preliminary assessment and have determined that this statement will not have a material impact on us upon adoption.
     In December 2004, the FASB issued SFAS No. 123R “Share-Based Payment.” SFAS No. 123R is a revision of SFAS No. 123 “Accounting for Stock-Based Compensation.” This Statement supersedes APB Opinion No. 25, “Accounting for Stock Issued to Employees,” and its related implementation guidance. This Statement requires a public company to measure the cost of employee services received in exchange for an award of equity instruments based on the grant-date fair value of the award (with limited exceptions). That cost will be recognized over the period during which an employee is required to provide service in exchange for the award; the requisite service period (usually the vesting period). We are currently following APB No. 25 and applying the nominal vesting approach.

17


Table of Contents

     SFAS No. 123R upon adoption requires the application of the non-substantive vesting approach which means that an award is fully vested when the employee’s retention of the award is no longer contingent on providing subsequent service. This would be the case for awards that vest when employees become retirement eligible or awards granted to retirement eligible employees. Had we been using the non-substantive approach instead of the nominal vesting approach when calculating the effect on net income and earnings per share in Note 1 to the Consolidated Financial Statements, net income would have decreased by approximately $0.6 million and $2.0 million for the quarter and six months ended June 30, 2005, respectively and $2.3 million and $2.0 million for the quarter and six months ended June 30, 2004 respectively. SFAS No. 123R is effective as of the first annual reporting period that begins after June 15, 2005. We are currently in the process of evaluating which option pricing model to use when we implement SFAS No. 123R and thus we have not completed the estimate of the impact that this Statement will have on our financial results of operations.
     In December 2004, the FASB issued FASB Staff Position (“FSP”) No. FAS 109-1 “Application of FASB Statement No. 109, Accounting for Income Taxes, to the Tax Deduction on Qualified Production Activities Provided by the American Jobs Creation Act of 2004 (the “Act”).” This FSP was issued in response to tax deductions for certain qualified production activities provided by the Act, which was signed into law by the President of the United States on October 22, 2004. As a result of the Act, this FSP concludes that those deductions included in the Act should be accounted for as a special deduction in accordance with SFAS No. 109. This FSP is effective immediately. The Act provides a deduction for income from qualified domestic production activities, which will be phased-in from 2005 through 2010. In return, the Act provides for a two-year phase-out of the existing extra-territorial income exclusion (“ETI”) for foreign sales. We expect the net effect of the phase in of this new deduction and the phase-out of the ETI to not be significant based on current earnings levels. The special deduction treatment per this FSP has no effect on deferred tax assets and liabilities existing at the enactment date. Rather, the impact of this deduction will be reported in the period in which the deduction is claimed on our tax return.
     In December 2004, the FASB issued FSP No. FAS 109-2, “Accounting and Disclosure Guidelines for the Foreign Repatriation Provisions within the American Jobs Creation Act of 2004.” This FSP was issued in response to another provision of the Act that provides for temporary incentive for U.S. companies to repatriate accumulated income earned abroad and is effective immediately. This temporary incentive provides an 85% dividends received deduction for certain dividends from controlled foreign corporations. The deduction is subject to a number of limitations and as of today, we are not yet in a position to decide to what extent we might elect to use the repatriation provisions of the Act related to our foreign earnings. Because the majority of the Company’s foreign earnings are in higher-taxed countries, the benefits provided by the repatriation provision of the Act are, for the most part, benefits the Company was already receiving prior to the Act. Because of this, the repatriation provisions of the Act do not provide significant benefits to the Company.
OUTLOOK
The positive momentum we experienced in the first half of the year is expected to continue into the third quarter. Sales of our products to each of the markets we serve except to the fragrance/cosmetic market are expected to increase over the prior year. Sales of our products to the pharmaceutical market are expected to increase, particularly sales of our metered dose aerosol valves. Our sales to the food/beverage and personal care markets are expected to increase as customers continue to launch new products into these markets and the demand from these markets is expected to remain strong in the U.S.
     Raw material costs decreased slightly in the second quarter but remained higher compared to the prior year. If costs, particularly plastic resin costs, increased in the second half of the year as currently anticipated, this may have a negative impact on the anticipated results if delays or difficulties are encountered in passing through these additional costs to customers.
     We are initiating a program beginning in the third quarter of 2005 to redeploy and realign our workforce within our various production sites in France to better accommodate the growth we anticipate in the coming years as well as improve productivity. Approximately 160 people will be affected by this redeployment. The plan will be implemented over a three year period and will also involve the transfer of some machinery and equipment. While it is difficult to calculate an exact cost of this redeployment plan, it is expected that the first phase of the plan (to be implemented in September of 2005 and affecting approximately 50 people) will cost approximately $3 million and will be made up of costs including but not limited to relocation expenses, severance payments and early retirement costs.
     We anticipate diluted earnings per share for the third quarter of 2005 excluding any effects of this program to be in the range of $.70 to $.75 per share compared to $.68 per share in the third quarter of 2004.

18


Table of Contents

FORWARD-LOOKING STATEMENTS
This Management’s Discussion and Analysis and certain other sections of this Form 10-Q contain forward-looking statements that involve a number of risks and uncertainties. Words such as “expects,” “anticipates,” “believes,” “estimates,” and other similar expressions or future or conditional verbs such as “will,” “should,” “would” and “could” are intended to identify such forward-looking statements. Forward-looking statements are made pursuant to the safe harbor provisions of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 and are based on our beliefs as well as assumptions made by and information currently available to us. Accordingly, our actual results may differ materially from those expressed or implied in such forward-looking statements due to known or unknown risks and uncertainties that exist in our operations and business environment, including but not limited to:
  difficulties in product development and uncertainties related to the timing or outcome of product development;
  the cost and availability of raw materials;
  our ability to increase prices;
  our ability to contain costs and improve productivity;
  our ability to meet future cash flow estimates to support our goodwill impairment testing;
  direct or indirect consequences of acts of war or terrorism;
  difficulties in complying with government regulation;
  competition (particularly from Asia) and technological change;
  our ability to defend our intellectual property rights;
  the timing and magnitude of capital expenditures;
  our ability to identify potential acquisitions and to successfully acquire and integrate such operations or products;
  significant fluctuations in currency exchange rates;
  resolution of pending tax-related items;
  economic and market conditions worldwide;
  changes in customer spending levels;
  work stoppages due to labor disputes;
  the timing and recognition of the costs of the workforce redeployment program in France;
  the demand for existing and new products;
  other risks associated with our operations.
     Although we believe that our forward-looking statements are based on reasonable assumptions, there can be no assurance that actual results, performance or achievements will not differ materially from any future results, performance or achievements expressed or implied by such forward-looking statements. Readers are cautioned not to place undue reliance on forward-looking statements. We undertake no obligation to update publicly any forward-looking statements, whether as a result of new information, future events or otherwise.

19


Table of Contents

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
A significant number of our operations are located outside of the United States. Because of this, movements in exchange rates may have a significant impact on the translation of the financial condition and results of operations of our entities. Our primary foreign exchange exposure is to the Euro, but we also have foreign exchange exposure to South American and Asian currencies, among others. A weakening U.S. dollar relative to foreign currencies has an additive translation effect on our financial condition and results of operations. Conversely, a strengthening U.S. dollar has a dilutive effect.
     Additionally, we are a net importer of products produced in European countries with Euro based costs, into the U.S. and sold in U.S. dollars. A weaker dollar compared to the Euro makes imported European produced products more expensive, thus reducing operating income margins.
     We manage our exposures to foreign exchange principally with forward exchange contracts to hedge certain firm purchase and sales commitments and intercompany cash transactions denominated in foreign currencies.
     The table below provides information as of June 30, 2005 about our forward currency exchange contracts.
All the contracts expire before the end of the second quarter of 2006.
 
                 
            Average Contractual  
Buy/Sell   Contract Amount     Exchange Rate  
 
               
Euro/U.S. Dollar
  $ 29,905       1.2411  
Swiss Francs/Euro
    12,156       0.6521  
Euro/British Pounds
    7,375       0.6769  
British Pounds/Euro
    6,139       1.4918  
Euro/Swiss Francs
    5,414       1.5358  
Canadian Dollar/Euro
    5,381       0.6235  
Euro/Indonesian Rupiah
    1,896       12196.9700  
U.S. Dollar/Mexican Peso
    1,335       11.3105  
Euro/Japanese Yen
    1,274       132.7176  
Russian Ruble /Euro
    1,216       0.0286  
Other
    7,098          
           
Total
  $ 79,189          
 
             
     The other contracts in the above table represent contracts to buy or sell various other currencies (principally European, South American and Australian). As of June 30, 2005, we have recorded the fair value of foreign currency forward exchange contracts of $1.3 million in accounts payable and accrued liabilities in the balance sheet. All forward exchange contracts outstanding as of June 30, 2004 had an aggregate contract amount of $50.8 million.
     At June 30, 2005, we had a fixed-to-variable interest rate swap agreement with a notional principal value of $25 million which requires us to pay an average variable interest rate (which was 3.4% at June 30, 2005) and receive a fixed rate of 6.6%. The variable rate is adjusted semiannually based on London Interbank Offered Rates (“LIBOR”). Variations in market interest rates would produce changes in our net income. If interest rates increase by 100 basis points, net income related to the interest rate swap agreement would decrease by less than $200 thousand assuming a tax rate of 32%. As of June 30, 2005, we recorded the fair value of the fixed-to-variable interest rate swap agreement of $2.4 million in miscellaneous other assets with an offsetting adjustment to debt. No gain or loss was recorded in the income statement in 2005 since there was no hedge ineffectiveness.
ITEM 4. CONTROLS AND PROCEDURES
DISCLOSURE CONTROLS AND PROCEDURES
The Company’s management has evaluated, with the participation of the chief executive officer and chief financial officer of the Company, the effectiveness of the Company’s disclosure controls and procedures (as that term is defined in Rule 13a-15(e) under the Securities Exchange Act of 1934) as of June 30, 2005. Based on that evaluation, the chief executive officer and chief financial officer have concluded that these controls and procedures were effective as of such date.

20


Table of Contents

CHANGES IN INTERNAL CONTROL OVER FINANCIAL REPORTING
No change in the Company’s internal control over financial reporting (as such term is defined in Rule 13a-15(f) under the Securities Exchange Act of 1934) occurred during the Company’s fiscal quarter ended June 30, 2005 that materially affected, or is reasonably like to materially affect, the Company’s internal control over financial reporting.
PART II — OTHER INFORMATION
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
RECENT SALES OF UNREGISTERED SECURITIES
During the quarter ended June 30, 2005, the FCP Aptar Savings Plan (the “Plan”) purchased 960 shares of our common stock on behalf of the participants at an average price of $48.53 for an aggregate amount of $46,589. At June 30, 2005, the Plan owned 5,200 shares of our common stock. The employees of AptarGroup S.A.S. and Valois S.A.S., our subsidiaries, are eligible to participate in the Plan. All eligible participants are located outside of the United States. An independent agent purchases shares of common stock available under the Plan for cash on the open market and the Company issues no shares. The Company does not receive any proceeds from the purchase of common stock under the Plan. The agent under the Plan is Banque Nationale de Paris (BNP) Paribas Asset Management. No underwriters are used under the Plan. All shares are sold in reliance upon the exemption from registration under the Securities Act of 1933 provided by Regulation S promulgated under that Act.
ISSUER PURCHASES OF EQUITY SECURITIES
The following table summarizes the Company’s purchases of its securities for the quarter ended June 30, 2005:
                                 
                    Total Number of     Maximum Number  
                    Shares Purchased     of Shares that May  
                    as Part of Publicly     Yet Be Purchased  
    Total Number of     Average Price Paid     Announced Plans or     Under the Plans or  
Period   Shares Purchased     per Share     Programs     Programs  
 
                               
4/1 — 4/30/05
    289,300       $49.16       289,300       1,799,300  
5/1 — 5/31/05
    341,700       50.33       341,700       1,457,600  
6/1 — 6/30/05
                      1,457,600  
Total
    631,000     $49.79       631,000       1,457,600  
     On July 15, 2004, the Company announced that the Board of Directors authorized the repurchase of an additional two million shares of its outstanding common stock bringing the cumulative total repurchase authorization under the repurchase program to five million shares of the Company’s common stock. There is no expiration date for this repurchase program.
ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS
The annual meeting of stockholders was held on May 4, 2005. A vote was taken by ballot for the election of three directors to hold office until the 2008 Annual Meeting of Stockholders. The following nominees received the number of votes as set forth below:
                         
Nominee     For       Withheld       Broker Non-Votes  
King Harris
    30,514,005       608,206       -0-  
Peter Pfeiffer
    30,514,996       607,215       -0-  
Dr. Joanne C. Smith
    30,511,394       610,817       -0-  

21


Table of Contents

Continuing as directors with terms expiring in 2006 are Rodney L. Goldstein, Ralph Gruska, Dr. Leo A. Guthart and Prof. Dr. Robert W. Hacker. Continuing as directors with terms expiring in 2007 are Alain Chevassus, Stephen J. Hagge and Carl A. Siebel.
ITEM 6. EXHIBITS
Exhibit 31.1 Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
Exhibit 31.2 Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
Exhibit 32.1 Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
Exhibit 32.2 Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

22


Table of Contents

SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
AptarGroup, Inc.
(Registrant)
By /s/ Stephen J. Hagge
Stephen J. Hagge
Executive Vice President, Chief
Financial Officer and Secretary
(Duly Authorized Officer and
Principal Financial Officer)

Date: July 29, 2005

23


Table of Contents

INDEX OF EXHIBITS
     
Exhibit    
Number   Description
 
   
31.1
  Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
 
   
31.2
  Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
 
   
32.1
  Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
 
   
32.2
  Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.